ID: ALA4521919

Max Phase: Preclinical

Molecular Formula: C18H23N7O3

Molecular Weight: 385.43

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C=O)N(CCO)c1nc(-c2cnc(N)nc2)nc2c1C[C@@H]1COCCN21

Standard InChI:  InChI=1S/C18H23N7O3/c1-11(9-27)24(2-4-26)16-14-6-13-10-28-5-3-25(13)17(14)23-15(22-16)12-7-20-18(19)21-8-12/h7-9,11,13,26H,2-6,10H2,1H3,(H2,19,20,21)/t11?,13-/m1/s1

Standard InChI Key:  RFCQCOSQCVGWHQ-GLGOKHISSA-N

Associated Targets(Human)

Cytochrome P450 1A1 1169 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytochrome P450 1A2 26471 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 385.43Molecular Weight (Monoisotopic): 385.1862AlogP: -0.34#Rotatable Bonds: 6
Polar Surface Area: 130.59Molecular Species: NEUTRALHBA: 10HBD: 2
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.61CX LogP: 0.82CX LogD: 0.82
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.64Np Likeness Score: -0.58

References

1. Borsari C, Rageot D, Dall'Asen A, Bohnacker T, Melone A, Sele AM, Jackson E, Langlois JB, Beaufils F, Hebeisen P, Fabbro D, Hillmann P, Wymann MP..  (2019)  A Conformational Restriction Strategy for the Identification of a Highly Selective Pyrimido-pyrrolo-oxazine mTOR Inhibitor.,  62  (18): [PMID:31465220] [10.1021/acs.jmedchem.9b00972]

Source